(2S, 3S, 4R) -3- [[[(2S, 3S, 4R) - 3- Azido- 4- [[[(1, 1- dimethylethyl) dimethylsilyl] oxy] methyl] - 1- (phenylmethyl) - 2- azetid inyl] carbonyl] amino] - 4- [[[(1, 1- dimethylethyl) dimethylsilyl] oxy] methyl] - 1- (phenylmethyl) -2- azetidinecarb

Ref. 3D-MA163462

Produktinformation

• Name: (2S, 3S, 4R) -3- [[[(2S, 3S, 4R) - 3- Azido- 4- [[[(1, 1- dimethylethyl) dimethylsilyl] oxy] methyl] - 1- (phenylmethyl) - 2- azetid inyl] carbonyl] amino] - 4- [[[(1, 1- dimethylethyl) dimethylsilyl] oxy] methyl] - 1- (phenylmethyl) -2- azetidinecarb

Beschreibung

The synthesis starts with a commercially available, methyl-protected, phenyl-protected 2-azetidinecarboxylic acid. The carbonyl group is then converted to an amide by reaction with ammonia in the presence of a base (such as triethylamine) and an appropriate coupling agent (such as HOBt). The amide is then deprotected by treatment with hydrochloric acid to give the desired product. This compound has not been characterized fully yet but it is expected to be a complex carbohydrate.

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is an antituberculosis drug that belongs to the class of rifamycins. It is the most active of the rifamycins for the treatment of tuberculosis. Rifapentine inhibits bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. The high frequency of human activity has

• Marke: Biosynth

Chemische Eigenschaften

• Reinheit: Min. 95%